HD6610 Granule
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HD6610 Granule, covering 2015-12-02 to 2015-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy [Phase 2, Phase 3]